FDA’s Concerns about Zoloft Birth Defects
The federal government’s Food and Drug Administration (FDA) recently issued an updated warning that encouraged medical professionals to report adverse events related to Zoloft ingestion during pregnancy to the FDA’s MedWatch Program.
The reason for the FDA’s observation of Zoloft (sertraline) and similar SSRI antidepressants is understandable: in the last decade thousands of American women have reported giving birth to infants suffering from a host of prenatal birth defects, including persistent pulmonary hypertension (PPHN), and heart, brain, and physical birth defects. Many of these patients and their families are concerned that Zoloft may have played an important causal role in their child’s injury.
Do you have concerns about the relationship between your child’s birth defects and your Zoloft prescription? The attorneys and professionals at the Dallas-based law firm of Fears Nachawati may be able to help you. Thanks to our experience and expertise, we know how to fight for victims just like you. For a free consultation, call us at 1.866.545.8364 or email email@example.com. We’re ready to fight for you!